-+ 0.00%
-+ 0.00%
-+ 0.00%

Aimei Health risks Nasdaq delisting after market value falls below $50 million threshold

PUBT·08/26/2026 11:51:36
Listen to the news
Aimei Health risks Nasdaq delisting after market value falls below $50 million threshold
  • Aimei Health Technology received Nasdaq notices for failing Global Market market-value thresholds, raising the risk of a delisting process.
  • Market value of listed securities stayed below USD 50 million for 30 straight business days, breaching Nasdaq Rule 5450(b)(2)(A).
  • Market value of publicly held shares also fell below USD 15 million for 30 straight business days, breaching Nasdaq Rule 5450(b)(2)(C).
  • Shares continue trading under AFJK, with 180 days to regain compliance by Feb. 17, 2027.
  • Failure to cure could trigger a delisting notice, or a potential transfer application to the Nasdaq Capital Market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040044), on August 25, 2026, and is solely responsible for the information contained therein.